29 citations
,
March 2012 in “Stem Cell Research & Therapy”
This article explores questions about dormant hematopoietic stem cells and suggests avenues for future research, but does not present new experimental results.
1 citations
,
January 2012 in “Pigment Cell & Melanoma Research”
This study identified key components of melanocyte stemcell niches that maintain stem cells in a dormant state and established a culture system that potentially replicates some aspects of in vivo stemcell activity.
This study found that the circadian clock regulates the activation state of murine epidermal stem cells, affecting tissue homeostasis and susceptibility to tumorigenesis when disrupted.
124 citations
,
February 2018 in “Nature Reviews Genetics”
This review covers recent findings on stemcell plasticity under normal and cancerous conditions but presents no new experimental results, highlighting implications for regenerative medicine and cancer treatments.
This study introduces stemcell activity as a key factor influencing the effects of IFN-γ and TGF-β1 on autoimmune disease dynamics, showing that varying cytokine levels can modulate stemcell activity and immune privilege, impacting tissue regeneration and disease flares.
PP405 is ineffective for miniaturized, fibrosed hair follicles in androgenetic alopecia. AMP303 may activate hair follicle stem cells, but minoxidil and finasteride are still the main treatments.
PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.
PP405 may damage hair follicles if used long-term, suggesting cycling might be necessary. Combining it with finasteride could help maintain hair growth.
PP405 may encourage earlier hair growth and slightly increase visible hair count but does not reverse hair follicle miniaturization in male pattern baldness. It does not address damage to the dermal papilla or broken Wnt signaling.
The conversation discusses the complexity of reversing hair loss and the need for a treatment that specifically targets DHT levels without affecting other bodily functions. It mentions finasteride as a current treatment but highlights the desire for a solution that works solely on the scalp.